Nearly a quarter-of-a-million people are expected to receive the Mounjaro jab over the next three years. NHS officials have ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

Health Secretary Wes Streeting has suggested that new weight loss injections such as Ozempic or Mounjaro could be given to ...

All the evidence gathered from the five-year trial will be used to demonstrate the long-term effect of weight loss medication ...

The weight loss jab Mounjaro will soon be made available to nearly a quarter of a million NHS patients, according to proposals made by the National Institute for Health and Care Excellence (Nice).

The weight loss jab Mounjaro will soon be made available to nearly a quarter of a million NHS patients, according to proposals made by the National Institute for Health and Care Excellence (Nice).

Dubbed the “King Kong” of weight loss jabs, Mounjaro, the brand name for tirzepatide, is a weekly injection licensed to treat type 2 diabetes on the NHS. Trials have shown some users can lose ...

The injection, known as Mounjaro and made by Eli Lilly, is used to treat type 2 diabetes and has been shown in clinical trials to be more effective in weight loss than diet and exercise support alone.

(MENAFN- The Conversation) The weight loss jab Mounjaro will soon be made available to nearly a quarter of a million NHS patients, according to proposals made by the National Institute for health ...